1 study found for:    21865319 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I Trial of Silymarin for Chronic Liver Diseases
Conditions: Hepatitis C;   Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Placebo;   Drug: Silymarin

Indicates status has not been verified in more than two years